Latest Breaking News On - Michael molyneaux - Page 2 : comparemela.com

Sirnaomics Reports Interim Results of STP705 Phase I Clinical Study for Medical Aesthetics Treatment in Adults Undergoing Abdominoplasty

Sirnaomics Reports Interim Results of STP705 Phase I Clinical Study for Medical Aesthetics Treatment in Adults Undergoing Abdominoplasty
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMiller schoolUniversity of miamiMichael molyneauxPatrick luMark nestorDivision of plastic surgeryDrug administrationSirnaomics ltdGroup or sirnaomicsChinese national medical productsPrnewswire sirnaomics ltd the companyStock codeLocal skin reactionsCosmetic enhancementPlastic surgery

Sirnaomics Dosed the First Patient in Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment

/PRNewswire/ Sirnaomics Ltd. (the "Company"; together with its subsidiaries, the "Group" or "Sirnaomics"; stock code: 2257), a leading biopharmaceutical.

Patrick luMichael molyneauxGroup or sirnaomicsGroup galaheadPrnewswire sirnaomics ltdAtrial fibrillationExecutive directorChief medical officerChief executive officer

Sirnaomics Launches Phase I Clinical Trial for GalNAc Factor XI Program

Sirnaomics Launches Phase I Clinical Trial for GalNAc Factor XI Program
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMichael molyneauxDmitry samarskyPatrick luGroup galnac factor xi programSirnaomics ltdDrug administrationInvestigational new drugStock codeExecutive directorChief medical officerChief technology officerPolypeptide nanoparticle formulation

Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers

/PRNewswire/ Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi.

United statesMichael molyneauxPatrick luInternational agency for research on cancerA world health organizationDrug administrationPrnewswire sirnaomics ltdCompany or sirnaomicsSquamous cell carcinomaBasal cell carcinomaExecutive directorChief medical officerAdverse eventsSerious adverse eventsExtramammary pagetWorld health organization

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongNigel yipBunny leeAlexis feinbergMichael molyneauxPatrick luLysine coSirnaomics ltdAnnounces interim dataPhasei clinical trialMultiple solidSuzhou biobayStock codeExecutive directorChief medical officer